Urologic Diseases  >>  Inlyta (axitinib) 
Welcome,         Profile    Billing    Logout  

1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlyta (axitinib) / Pfizer
NCT01473043: Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

No Longer Available
N/A
Canada, RoW
Axitinib, AG-013736
Pfizer
Renal Cell Carcinoma
03/14
03/14

Download Options